Novo Nordisk competitor halts generic medicine supply

Hims and Hers announced a halt in sales of their copy of the weight-loss drug, Wegovy.

This decision followed talks with stakeholders. Initially, Hims and Hers planned to offer the drug at $49, compared to the $149 price of Wegovy by Novo Nordisk.

The withdrawal may impact financial results,...